Advancing Science Against the World’s Most Serious Diseases
For more than 35 years, Gilead has pursued extraordinary science to confront the world’s most serious diseases. Over 25 life-changing medicines have been developed to treat, prevent, and transform conditions that impact millions of people. Our research and development team brings together scientific excellence, collaboration, and purpose to deliver impact that grows exponentially.
Learn MoreGilead is pioneering transformative therapies that can extend and improve lives, from antiviral breakthroughs to next-generation cell and molecular treatments, across virology, oncology and inflammation.
Explore Therapeutic AreasActive clinical programs in development
Invested in research and development in 2024
Employees advancing research, development and manufacturing
Research Funding Programs
We actively support innovative research that addresses critical patient needs. Gilead offers a number of opportunities to advance studies that align with our mission.
View Research Funding ProgramsLatest Research Publications
Some of the content on this page is not intended for users outside the U.S.
Clinical Trials
We're committed to involving the communities most impacted by disease in the design and execution of our clinical trials.
Medicines
We have developed more than 25 life-changing medicines to treat, prevent and transform conditions that impact millions of people and are rapidly growing our portfolio through research, development and external collaborations.
Gilead's
Research Sites
With a network of state-of-the-art R&D facilities, Gilead continually pushes the boundaries of scientific discovery and drug development.
Grow With Us
With more than 17,000 employees spanning across 35+ countries on six continents, Gilead has a global workforce dedicated to creating a healthier world for everyone.
Explore Opportunities